A randomized, double-blind, placebo-controlled, phase 2 study to assess safety, tolerability and efficacy of RT001 in patients with amyotrophic lateral sclerosis.

Daphne N Weemering,Mark Midei,Peter Milner, Vidhya Gopalakrishnan,Anil Kumar, Andrew J Dannenberg,Tommy M Bunte,Juliette Foucher,Caroline Ingre,Viktorija Ķēniņa, Karin Rallmann,Leonard H van den Berg,Ruben P A van Eijk

European journal of neurology（2023）

引用 0|浏览5

暂无评分

摘要

Initial data indicate that RT001 is safe and well-tolerated. Given the exploratory nature of the study, a larger clinical trial is required to evaluate its efficacy.

查看译文

关键词

amyotrophic lateral sclerosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要